← Leaderboards
Andrew Yee
Baylor College Of Medicine
$1,239,993
Attributed
$2,479,986
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $773.5K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,479,986 · 2
By mechanism
R01$2,038,611 · 1
R21$441,375 · 1
Top collaborators
- Miguel Angel Cruz7 shared
- Sarah Elizabeth Sartain2 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Marisa Ellen Hilliard$5,657,462
- Miguel Angel Cruz$5,719,394
- Wolfgang Christoph Winkelmayer$6,066,937
- Elizabeth M Vaughan$4,138,795
- Rubina A Heptulla$4,982,785
Others in their field
Other Emerging Leaders on “Biochemical”
- John Damon Chodera · Sloan-Kettering Inst Can Research$47,159,667
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Robert J Woods · Virginia Polytechnic Institute And State University$12,760,318
- Bryan Roth · Univ Of North Carolina Chapel Hill$12,367,722
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Neil King · University Of Washington$9,764,305
Research focus
BiochemicalMediatingFibrinogenFoundationsBindingComplexThromboticFibrinolytic AgentsFibrinMolecular ConformationAdhesionsAntibodiesAdsorptionHemorrhageComplicationExposure ToHemoglobinFormalinHemoglobin Concentration ResultDevicesHemolysisEnhancing FactorBlood PlateletsMolecular
Grant awards (9)
Role of tissue kallikrein in alternative complement pathway activation in STEC-HUS$200,625
R21 · FY2025 · AI
Molecular Studies of Hemolytic Thrombosis$464,096
R01 · FY2024 · HL
Role of tissue kallikrein in alternative complement pathway activation in STEC-HUS$240,750
R21 · FY2024 · AI
Molecular Studies of Hemolytic Thrombosis$68,674
R01 · FY2024 · HL
Molecular Studies of Hemolytic Thrombosis$480,933
R01 · FY2023 · HL
Molecular Studies of Hemolytic Thrombosis$68,674
R01 · FY2023 · HL
Molecular Studies of Hemolytic Thrombosis$30,294
R01 · FY2023 · HL
Molecular Studies of Hemolytic Thrombosis$438,603
R01 · FY2022 · HL
Molecular Studies of Hemolytic Thrombosis$487,337
R01 · FY2021 · HL